A comparative study of efficacy and safety of alcaftadine 0.25% versus olopatadine hydrochloride 0.2% in allergic conjunctivitis at a tertiary care hospital

Míreanna comhchosúla

• Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis
  de réir: Lakshey Dudeja, et al.
  Foilsithe / Cruthaithe: (2019-01-01)
• A comparative study of efficacy and tolerability of bepotastine besilate (1.5%) and olopatadine hydrochloride (0.1%) eye drops in allergic conjunctivitis in a tertiary care hospital of the southern part of India
  de réir: Sudipto Chatterjee, et al.
  Foilsithe / Cruthaithe: (2024-10-01)
• Comparative observational analysis of clinical outcomes in patients of vernal keratoconjunctivitis treated with eye drops olopatadine or bepotastine besilate
  de réir: Preeti Yadav, et al.
  Foilsithe / Cruthaithe: (2022-01-01)
• Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis
  de réir: Marini MC, et al.
  Foilsithe / Cruthaithe: (2023-11-01)
• A pharmacoeconomic study of olopatadine hydrochloride 0.1% eye drops and bepotastine besilate 1.5% eye drops in the management of allergic conjunctivitis: A cost-effectiveness analysis
  de réir: Sudipto Chatterjee, et al.
  Foilsithe / Cruthaithe: (2026-03-01)